RETRACTED: Systematic Review of Economic Evaluation Literature in Ghana: Is Health Technology Assessment the Future? (Value in Health Regional Issues (2013) 2(2) (279–283), (S221210991300085X) (10.1016/j.vhri.2013.07.006));Systematic review of economic evaluation literature in Ghana: Is health technology assessment the future?

Value in Health Regional Issues

Volumn 2, Issue 2, 2013, Pages 279-283

  Odame, Emmanuel Ankrah ^a  

^a Ghana College of Physicians and Surgeons   (Ghana)

Author keywords

Economic evaluation; Ghana; Medical devices; Pharmaceuticals

Indexed keywords

ARTICLE; COST; DECISION MAKING; ECONOMIC EVALUATION; GHANA; HEALTH CARE POLICY; HEALTH IMPACT ASSESSMENT; HEALTH SERVICE; MEDICAL DEVICE; NATIONAL HEALTH INSURANCE; PHARMACEUTICS; PRIORITY JOURNAL; PUBLICATION; QUALITY CONTROL; RESOURCE ALLOCATION; SYSTEMATIC REVIEW;

EID: 84884132277     PISSN: 22121099     EISSN: 22121102     Source Type: Journal    
DOI: 10.1016/j.vhri.2019.01.001     Document Type: Erratum

References (29)

1. Anonymous. Health technology assessment. Available from:. [Accessed November 28, 2012]. http://www.inahta.org/HTA/.
2. Drummond M.F., Schwartz J.S., Jonsson B., et al. Key principles for the improved conduct of health technology assessments for resource allocation decisions. Int J Technol Assess Health Care 2008, 24:244-258.
3. Cairns J. Discounting in economic evaluation. Economic Evaluation in Health Care: Merging Theory with Practice 2001, Oxford University Press, Oxford. M. Drummond, A. McGuire (Eds.).
4. Drummond M., Pang F. Transferability of economic evaluation results. Economic Evaluation in Health Care 2001, Oxford University Press, Oxford. M. Drummond, A. McGuire (Eds.).
5. Mathew J.L. KNOW ESSENTIALS: a tool for informed decisions in the absence of formal HTA systems. Int J Technol Assess Health Care 2011, 27:139-150.
6. Chalkidou K., Levine R., Dillon A. Helping poorer countries make locally informed health decisions. BMJ 2010, 341:c3651.
7. Drummond M.F., Jefferson T.O. Guidelines for authors and peer reviewers of economic submissions to the BMJ. BMJ 1996, 313:275-283.
8. Drummond M., Sculpher M., Torrance G., et al. Method for the Economic Evaluation of Health Care Programmes 2005, Oxford University Press, Oxford. 3rd ed.
9. Pichon-Riviere A., Augustovski F., Rubinstein A., et al. Health technology assessment for resource allocation decisions: are key principles relevant for Latin America?. Int J Technol Assess Health Care 2010, 26:421-427.
10. Drummond M., Sculpher M. Common methodological flaws in economic evaluations. Med Care 2005, 43(7, Suppl.):5-14.
11. Piñeros M., Wiesner C., Cortés C., Trujillo L.M. HPV vaccine introduction at the local level in a developing country: attitudes and criteria among key actors. Cad Saude Publica 2010, 26:900-908.
12. Kahveci R., Meads C. Analysis of strengths, weaknesses, opportunities, and threats in the development of a health technology assessment program in Turkey. Int J Technol Assess Health Care 2008, 24:235-240.
13. Lee KS, Brouwer WB, Lee SI, et al. Introducing economic evaluation as a policy tool in Korea: will decision makers get quality information? A critical review of published Korean economic evaluations. Pharmacoeconomics 2005;23:709-21.
14. Neumann P. Using Cost-Effectiveness Analysis to Improve Health Care: Opportunities and Barriers 2005, Oxford University Press, Oxford.
15. Recommendations on immunization, 2008. Ind Pediatr 2008, 45:635-648. Indian Academy of Pediatrics Committee on Immunization.
16. Seoane-Vazquez E., Rodriguez-Monguio R. Negotiating antiretroviral drug prices: the experience of the Andean countries. Health Policy Plan 2007, 22:63-72.
17. Oliver A. Health economic evaluation in Japan: a case study of: one aspect of health technology assessment. Health Policy 2003, 63:197-204.
18. Coast J. Is economic evaluation in touch with society's health values?. BMJ 2004, 329:1233-1236.
19. Tan-Torres E., Baltussen R., Adum T., et al. Making CHOICES in Health: WHO Guide to Cost-Effectiveness Analysis 2003, World Health Organization, Geneva.
20. Mittal S.K., Mathew J.L. Polio eradication in India: the way forward. Ind J Pediatr 2007, 74:153-160.
21. Vancelik S., Beyhun N.E., Acemoglu H., Calikoglu O. Impact of pharmaceutical promotion on prescribing decisions of general practitioners in Eastern Turkey. BMC Public Health 2007, 7:122.
22. Republic of Rwanda, Ministry of Financial Planning, Ministry of Health. Scaling up to achieve the health MDGs in Rwanda. 2006. Available from:. [Accessed May 16, 2009]. http://www.oecd.org/dataoecd/34/39/37759625.pdf.
23. Teerawattananon Y., Russell S., Mugford M. Systematic review of economic evaluation literature in Thailand-are the data good enough to be used by policy makers?. Pharmacoeconomics 2007, 25:467-479.
24. Mathew J.L. Pneumococcal vaccination in developing countries: where does science end and commerce begin?. Vaccine 2009, 27:4247-4251.
25. Howitt P., Darzi A., Yang G.-Z., et al. Technologies for global health. Lancet 2012, 380:507-535.
26. Doherty J., Kamae I., Lee K.K.C., et al. What is next for pharmacoeconomics and outcomes research in Asia?. Value Health 2004, 7:118-132.
27. Carapinha J.L., Ross-Degnan D., Wagner A.K. Health insurance systems in five sub-Saharan African countries: medicine benefits and data for decision making. Health Policy 2011, 99:193-202.
28. European Commission. COUNCIL DIRECTIVE 93/42/EEC of 14 June 1993 concerning medical devices.
29. Daar A.S., Thorsteinsdóttir H., Martin D.K., et al. Top ten biotechnologies for improving health in developing countries. Nat Genet 2002, 32:229-232.